Roche Gains Rights to Hanmi Obesity Drug That Reduces Fat, Preserves Muscle
Hanmi Pharmaceutical’s drug is designed to activate a receptor in skeletal muscle to both increase muscle mass and reduce fat. This engineered peptide gives Roche
Hanmi Pharmaceutical’s drug is designed to activate a receptor in skeletal muscle to both increase muscle mass and reduce fat. This engineered peptide gives Roche
[Sponsored] Discover how payers can shift from costly post-payment recovery to intentional prevention through data-driven oversight, accountability, and partnership. The post A Partnership-driven Approach to
Metabolic psychiatry has moved past being a fringe theory. It is a practical, evidence-based necessity for a field that has been stagnant for too long.
A new paper shows Cleveland Clinic’s AI scribe rollout is paying dividends in clinician satisfaction and retention. These are key metrics for hospitals to track,
Abcuro will apply the capital to a study that could support a biologics license application in inclusion body myositis, a rare inflammatory disorder that leads
Cityblock Health plans to acquire rural healthcare provider Homeward Health and has raised $116 million to expand its value-based care model to rural and Medicare
HealthGility provides healthcare organizations with a solution for patient protected health information disclosure and confidentiality that reduces workloads and ensures the safe and secure sharing of sensitive data between different providers.